The Valley Desk

NCT06256484 · Interventional trial

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Overall registry status Terminated

Phase 1

Conditions Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov